Analysts expect Kezar Life Sciences, Inc. (NASDAQ:KZR) to report $-0.49 EPS on August, 8.They anticipate $2.82 EPS change or 85.20 % from last quarter’s $-3.31 EPS. After having $-0.40 EPS previo

https://coinglobalist.com/kezar-life-sciences-inc-kzr-eps-estimated-at-0-49/